Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mouth Neoplasms 1

Interventions

Paclitaxel 2 Carboplatin 2 pembrolizumab 1 iso-sulfan blue 1 camrelizumab 1 Watchful Waiting 1 Taxes 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Adjuvant 1 Positron Emission Tomography Computed Tomography 1 Observation 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Immune Checkpoint Inhibitors 1 Chemoradiotherapy 1 Cetuximab 1 Capecitabine 1 Biopsy 1 Aminolevulinic Acid 1 (225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Mouth Neoplasms × iso-sulfan blue × Clear all

NCT07518485 2026-04-08

preReDSeL

Centre Hospitalier Universitaire Vaudois

Phase 2 Not yet recruiting

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡